Aevi Genomic Medicine (Formerly Known As Medgenics)

193 articles with Aevi Genomic Medicine (Formerly Known As Medgenics)

• Aevi Genomic Medicine Announces Completion of $28 Million Private Placement

  10/18/2017

  Aevi Genomic Medicine today announced the completion of a previously announced private placement of 22.2M shares of its common stock with warrants to purchase approximately 4.0M additional shares of its common stock, for aggregate proceeds of $28M, before expenses.

• Aevi Genomic Medicine Reports Second Quarter 2017 Financial Results

  8/10/2017

• Aevi Genomic Medicine Announces Agreement For $28 Million Private Placement

  8/10/2017

• Aevi Genomic Medicine Announces Plans To Initiate Phase II Clinical Trial To Confirm Genetic Responders To AEVI-001 And First Quarter 2017 Operating Results

  5/11/2017

• Aevi Genomic Medicine To Host Conference Call To Announce First Quarter And Discuss Recent Business Updates

  5/4/2017

• Aevi Genomic Medicine Presents Updated Results From SAGA Trial Of AEVI-001 At The 6th World Congress On ADHD

  4/25/2017

• Aevi Genomic Medicine To Present Updated Results From SAGA Trial Of AEVI-001 At The 6th World Congress On ADHD

  4/13/2017

• Aevi Genomic Medicine To Present At The 16th Annual Needham Healthcare Conference

  3/31/2017

• Aevi Genomic Medicine Craters as ADHD Drug Flunks Early-Stage Study

  3/20/2017

• Aevi Genomic Medicine Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Business Update

  3/10/2017

• Aevi Genomic Medicine Announces Expansion Of Its Collaboration With Children's Hospital of Philadelphia

  2/22/2017

• Aevi Genomic Medicine Announces 2017 Investor Day

  2/15/2017

• Aevi Genomic Medicine Announces Enrollment Of First Patient In Phase 1/2 Clinical Trial Of AEVI-001 In 22q Deletion Syndrome

  1/31/2017

• Medgenics, Inc. Announces Name Change To Aevi Genomic Medicine, Inc.

  12/15/2016

• Medgenics, Inc. Reports Third Quarter 2016 Financial Results

  11/4/2016

• Medgenics, Inc. Presents New Data Showing Prevalence Of Genetic Mutations In Pediatric Populations With Attention Deficit Hyperactivity Disorder

  10/31/2016

• Medgenics, Inc. To Host Conference Call To Announce Third Quarter 2016 Financial Results

  10/27/2016

• Medgenics, Inc. To Begin Trading On NASDAQ Global Market

  10/11/2016

• Medgenics, Inc. To Begin Trading On NASDAQ Global Market

  10/11/2016

• Medgenics, Inc. To Present At The Rodman & Renshaw 18th Annual Global Investment Conference

  9/6/2016